Radiolabeling of a monoclonal antibody with N-succinimidyl para-[77Br]bromobenzoate.
A preliminary study involving the radiolabeling of an anti-melanoma antibody through conjugation of a radiobrominated small molecule, N-succinimidyl para-[77Br]bromobenzoate, has been accomplished in 22% overall yield when no-carrier-added radiobromine was employed. In vitro analyses demonstrated that the radiobrominated antibody was immunocompetent, retaining 80% of the unlabeled antibody immunoreactivity.